In 2007, 14 disorders were added to the NMS panel: carnitine uptake defect (CUD), citrullinemia (CIT), congenital adrenal hyperplasia (CAH), cystic fibrosis (CF), glutaric acidemia type 1 (GA1), 3-hydroxy-3-methylglutaryl-CoA lyase (HMG) deficiency, isovaleric acidemia (IVA), long chain hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, maple syrup urine disease (MSUD), medium chain acyl-CoA dehydrogenase (MCAD) deficiency, methylmalonic acidemia (MMA), propionic acidemia (PA), trifunctional protein (TFP) deficiency, and very long chain acyl-CoA dehydrogenase (VLCAD) deficiency. This evidence concerns the gene HMGCL and maple syrup urine disease.